Bruker Corp (BRKR)
70.67
+0.23
(+0.33%)
USD |
NASDAQ |
Sep 27, 16:00
70.73
+0.06
(+0.08%)
After-Hours: 20:00
Bruker Research and Development Expense (Annual): 294.80M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 294.80M |
| December 31, 2022 | 235.90M |
| December 31, 2021 | 220.80M |
| December 31, 2020 | 198.00M |
| December 31, 2019 | 187.70M |
| December 31, 2018 | 173.40M |
| December 31, 2017 | 161.60M |
| December 31, 2016 | 147.90M |
| December 31, 2015 | 145.70M |
| December 31, 2014 | 174.20M |
| December 31, 2013 | 190.50M |
| December 31, 2012 | 195.30M |
| December 31, 2011 | 177.20M |
| Date | Value |
|---|---|
| December 31, 2010 | 141.40M |
| December 31, 2009 | 126.40M |
| December 31, 2008 | 133.80M |
| December 31, 2007 | 110.80M |
| December 31, 2006 | 49.96M |
| December 31, 2005 | 47.50M |
| December 31, 2004 | 48.36M |
| December 31, 2003 | 38.03M |
| December 31, 2002 | 30.64M |
| December 31, 2001 | 26.21M |
| December 31, 2000 | 20.03M |
| December 31, 1999 | 15.14M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
187.70M
Minimum
2019
294.80M
Maximum
2023
227.44M
Average
220.80M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Bio-Rad Laboratories Inc | 247.43M |
| Azenta Inc | 33.96M |
| Harvard Bioscience Inc | 11.76M |
| Bionano Genomics Inc | 54.03M |
| Akoya Biosciences Inc | 21.89M |